Literature DB >> 14574073

Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response.

Atul Aggarwal1, David J Schneider, Edward F Terrien, Kristin E Gilbert, Harold L Dauerman.   

Abstract

BACKGROUND: Inflammation after coronary stenting presages adverse outcomes after percutaneous coronary intervention (PCI). While changes in inflammatory markers have been defined 24-72 hours after PCI, potential changes during the first few hours have not. This study was designed to determine if a systemic inflammatory response could be measured within the first hour after stenting.
METHODS: Patients (n = 25) undergoing coronary stenting, with predominantly (n = 23) acute coronary syndromes were enrolled prospectively in this registry. Blood samples were collected before PCI, and 10 minutes, 1 hour and 18-24 hours later. No patient received a glycoprotein IIb-IIIa inhibitor. Concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-1 receptor antagonist (IL-1Ra) and soluble CD40 ligand (sCD40L) were measured using ELISA.
RESULTS: CRP and sCD40L did not change in the first hour after stenting. By contrast, IL-6 increased in the first hour (before = 7.6 +/- 7.7 pg/ml, 1 hour = 12 +/- 12 pg/ml; p < 0.001). The concentration of IL-1Ra tended to be greater after 1 hour (before = 426 +/- 261 pg/ml, 1 hour = 511 +/- 406 pg/ml; p = 0.11). Increase in IL-1Ra was apparent only in female subjects (p = 0.004 for the difference in trend between the two genders). A correlation was not observed between the increase in IL-6 at 1 hour and the increase in CRP at 24 hours (r = -0.21).
CONCLUSIONS: In patients undergoing coronary stenting, increase in IL-6 can be detected 1 hour after PCI, and thus IL-6 may be an early initiator of the systemic inflammatory response to stenting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574073     DOI: 10.1023/a:1026188200939

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  26 in total

1.  Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.

Authors:  D Zanger; B K Yang; J Ardans; M A Waclawiw; G Csako; L M Wahl; R O Cannon
Journal:  J Am Coll Cardiol       Date:  2000-11-15       Impact factor: 24.094

2.  Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting.

Authors:  Atul Aggarwal; David J Schneider; Edward F Terrien; Christopher M Terrien; Burton E Sobel; Harold L Dauerman
Journal:  Am J Cardiol       Date:  2003-06-01       Impact factor: 2.778

3.  Unstable angina. A classification.

Authors:  E Braunwald
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

4.  Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation.

Authors:  D H Walter; S Fichtlscherer; M Sellwig; W Auch-Schwelk; V Schächinger; A M Zeiher
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

5.  Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty.

Authors:  A Buffon; G Liuzzo; L M Biasucci; P Pasqualetti; V Ramazzotti; A G Rebuzzi; F Crea; A Maseri
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

6.  Coronary angioplasty induces a systemic inflammatory response.

Authors:  R R Azar; R G McKay; F J Kiernan; B Seecharran; Y J Feng; D B Fram; A H Wu; D D Waters
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

7.  Soluble CD40 ligand in acute coronary syndromes.

Authors:  Christopher Heeschen; Stefanie Dimmeler; Christian W Hamm; Marcel J van den Brand; Eric Boersma; Andreas M Zeiher; Maarten L Simoons
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

8.  Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.

Authors:  G Liuzzo; A Buffon; L M Biasucci; J R Gallimore; G Caligiuri; A Vitelli; S Altamura; G Ciliberto; A G Rebuzzi; F Crea; M B Pepys; A Maseri
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

9.  Elevated levels of interleukin-6 in unstable angina.

Authors:  L M Biasucci; A Vitelli; G Liuzzo; S Altamura; G Caligiuri; C Monaco; A G Rebuzzi; G Ciliberto; A Maseri
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves.

Authors:  Peter Alter; Jutta Hoeschen; Michael Ritter; Bernhard Maisch
Journal:  Am J Cardiol       Date:  2002-06-15       Impact factor: 2.778

View more
  6 in total

1.  Cardiac release and kinetics of cytokines after elective bare metal coronary stenting.

Authors:  NourEddine ElMokhtari; Sascha Zschernitz; Susanne Sebens; Gunhild Simon-Herrmann; Dietmar Krüger
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

2.  Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.

Authors:  Johanna A Miettinen; Kari Ylitalo; Pirjo Hedberg; Kari Kervinen; Matti Niemelä; Marjaana Säily; Pirjo Koistinen; Eeva-Riitta Savolainen; Heikki Ukkonen; Mikko Pietilä; K E Juhani Airaksinen; Juhani Knuuti; Olli Vuolteenaho; Timo H Mäkikallio; Heikki V Huikuri
Journal:  Clin Res Cardiol       Date:  2010-10-17       Impact factor: 5.460

3.  Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.

Authors:  Binita Shah; Michael Pillinger; Hua Zhong; Bruce Cronstein; Yuhe Xia; Jeffrey D Lorin; Nathaniel R Smilowitz; Frederick Feit; Nicole Ratnapala; Norma M Keller; Stuart D Katz
Journal:  Circ Cardiovasc Interv       Date:  2020-04-16       Impact factor: 6.546

4.  Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel.

Authors:  Shokoufeh Hajsadeghi; Mandana Chitsazan; Mitra Chitsazan; Negar Salehi; Ahmad Amin; Arash Amin Bidokhti; Nima Babaali; Armin Bordbar; Maral Hejrati; Samar Moghadami
Journal:  Clin Med Insights Cardiol       Date:  2016-08-29

5.  The upregulated scavenger receptor CD36 is associated with the progression of nontarget lesions after stent implantation in atherosclerotic rabbits.

Authors:  Ruijian Li; Sumei Cui; Youshun Xu; Junhui Xing; Li Xue; Yuguo Chen
Journal:  J Inflamm Res       Date:  2018-11-13

6.  Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, controlled study.

Authors:  Boris Schnorbus; Andreas Daiber; Kerstin Jurk; Silke Warnke; Jochem König; Ulrike Krahn; Karl Lackner; Thomas Munzel; Tommaso Gori
Journal:  BMJ Open       Date:  2014-05-06       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.